Home・Aktien・Pharming Group NV

P
Pharming Group NV

Geschlossen

1.139 -2.06

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.13

Max

1.1400000000000001

Schlüsselkennzahlen
By Trading Economics
Einkommen	21M 23M
Verkäufe	28M 118M
KGV Branchendurchschnitt	38.283 68.089
EPS	0.03
Gewinnspanne	19.048
Angestellte	407
EBITDA	26M 31M

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	67M 813M
Vorheriger Eröffnungskurs	3.2
Vorheriger Schlusskurs	1.139

Pharming Group NV Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Nov. 2026, 23:51 UTC

Canada's Housing Starts Data Set for November 17, Forecasting 243K Units Amid Cautious Optimism and Government Investment in Affordable Housing.

14. Nov. 2026, 23:41 UTC

Canada's Core Inflation Rate Release on November 16 Expected to Influence Monetary Policy Amidst Shifting Economic Sentiments and Global Supply Chain Concerns.

14. Nov. 2026, 23:41 UTC

Canada's Inflation Rate Release on November 16 Expected to Reflect Ongoing Economic Pressures Amid Global Trends.

14. Nov. 2026, 23:41 UTC

Mortgage Rates Expected to Decline Further Amid Mixed Economic Sentiment and Rising Inflation Concerns

14. Nov. 2026, 23:41 UTC

Canada's October Inflation Rate Expected to Rise 0.3%, Amid Global Economic Concerns and Resilient Domestic Growth

14. Nov. 2026, 23:41 UTC

NY Empire State Manufacturing Index Forecasted at 17.6 Amid Inflation Concerns and Tech Leadership Turmoil Impacting Investor Confidence.

14. Nov. 2026, 23:31 UTC

Australia's Unemployment Rate Expected at 4.7% Amidst Market Downturn and Rising Inflation Concerns

14. Nov. 2026, 23:31 UTC

UK Consumer Confidence Expected to Remain Low at -22.0 Amid Rising Inflation and Economic Uncertainty

14. Nov. 2026, 23:31 UTC

Australia's Full Time Employment Change report on November 19, 2026, comes amid cautious economic sentiment and concerns over job quality and inflation.

14. Nov. 2026, 23:31 UTC

Australia's Employment Change report on November 19, 2026, expected to show a cautious increase of 25.2K jobs amid market volatility and economic concerns.

14. Nov. 2026, 23:31 UTC

China's House Price Index set for release amid signs of stabilization and geopolitical tensions impacting market sentiment.

14. Nov. 2026, 23:01 UTC

News

Ethereum fell sharply, continuing a downward trend amid concerns over inflation data, rising yields, and a nationwide FAA outage affecting economic stability.

14. Nov. 2026, 23:01 UTC

News

Ethereum is sharply lower, pressured by recent inflation data, rising yields, and a nationwide FAA outage contributing to economic uncertainties.

14. Nov. 2026, 23:01 UTC

Correlated Moves

Cardano is experiencing a sharp decline, moving lower alongside Ethereum amid heightened volatility influenced by hawkish Federal Reserve remarks on inflation and interest rates.

14. Nov. 2026, 23:01 UTC

Correlated Moves

Avalanche is sharply lower, continuing a four-session decline amid a broader cryptocurrency market downturn, with Ethereum also trading lower following the Fed's inflation comments.

14. Nov. 2026, 23:01 UTC

Correlated Moves

XRP fell sharply, continuing an eleven-session decline, as Bitcoin's drop and hawkish Fed comments increased volatility in risk assets, including cryptocurrencies.

14. Nov. 2026, 23:01 UTC

News

Bitcoin is trading sharply lower amid broader market pressures from inflation concerns and rising yields, with a potential $1 billion debt crisis linked to Trump Media.

14. Nov. 2026, 23:01 UTC

Macro News

Ethereum is trading sharply lower, reflecting ongoing weakness amid a nationwide FAA outage and geopolitical tensions affecting market confidence since Friday's close.

14. Nov. 2026, 23:01 UTC

News

Bitcoin is trading sharply lower, continuing a decline since Friday, amid inflation concerns and Trump Media's potential $1 billion debt crisis linked to bitcoin investments.

14. Nov. 2026, 23:01 UTC

Macro News

Bitcoin is trading sharply lower, continuing a decline since Friday amid market volatility and concerns over Trump Media's potential $1 billion debt crisis linked to crypto.

14. Nov. 2026, 22:52 UTC

Japan's October Inflation Rate Release on November 19 Sparks Caution Amid Global Inflation Concerns and Yen Weakness.

14. Nov. 2026, 22:52 UTC

Japan's Core Inflation Rate for October 2026 is forecasted to rise slightly to 2.3%, amid mixed market expectations influenced by U.S. economic indicators and global monetary policy concerns, with potential impacts on the Bank of Japan’s strategies amidst geopolitical tensions affecting energy costs.

14. Nov. 2026, 22:52 UTC

Japan's Machinery Orders Expected to Decline 0.005% Amid Economic Volatility and Currency Fluctuations

14. Nov. 2026, 22:52 UTC

RBA Meeting Minutes on November 17, 2026, to reveal insights amid declining AUD and cautious interest rate sentiment influenced by global inflation and Fed policies.

14. Nov. 2026, 22:41 UTC

Macro News

Brent crude oil prices are modestly higher since Friday's close, influenced by a tanker fire near the Strait of Hormuz and collaborative reserve efforts among Southeast Asian nations.

14. Nov. 2026, 22:31 UTC

Japan's Trade Balance Report Set for November 17, Forecasting ¥956 Billion Deficit Amid Currency Concerns and Market Volatility.

14. Nov. 2026, 22:31 UTC

UK Manufacturing Sector Faces Continued Weakness as CBI Industrial Trends Orders Report Forecasts -29.0 for November 2026

14. Nov. 2026, 22:31 UTC

Japan's October Exports Data Set for Release Amid Cautious Optimism and Mixed Market Sentiment, Forecasting 0.2% Growth After September's Slower-than-Expected Increase

14. Nov. 2026, 22:21 UTC

Brazil's Central Bank to announce interest rate decisions on November 16, amid rising global yields and inflation concerns.

14. Nov. 2026, 21:51 UTC

Japan's Q3 2026 GDP Growth Rate Expected at Just 0.1% Amid Positive Stock Market Sentiment and Currency Volatility Concerns

Peer-Vergleich

Kursveränderung

Pharming Group NV Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Pharming Group NV – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.